Compound GLP-1s, Anesthesia Prices And More In Court
A Fifth Circuit panel heard arguments from compounding pharmacies alleging the U.S. Food and Drug Administration skipped procedural steps when removing their ability to create compound versions of certain GLP-1 weight...To view the full article, register now.
Already a subscriber? Click here to view full article